0001213900-20-045824.txt : 20201231
0001213900-20-045824.hdr.sgml : 20201231
20201231180752
ACCESSION NUMBER: 0001213900-20-045824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201229
FILED AS OF DATE: 20201231
DATE AS OF CHANGE: 20201231
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CROSKREY STEPHEN
CENTRAL INDEX KEY: 0001140350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39280
FILM NUMBER: 201429609
MAIL ADDRESS:
STREET 1: C/O ARMOR HOLDINGS INC
STREET 2: 1400 MARSH LANDING PARKWAY SUITE 112
CITY: JACKSONVILLE
STATE: FL
ZIP: 32250
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Danimer Scientific, Inc.
CENTRAL INDEX KEY: 0001779020
STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
IRS NUMBER: 841924518
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 140 INDUSTRIAL BOULEVARD
CITY: BAINBRIDGE
STATE: GA
ZIP: 39817
BUSINESS PHONE: 229-243-7075
MAIL ADDRESS:
STREET 1: 140 INDUSTRIAL BOULEVARD
CITY: BAINBRIDGE
STATE: GA
ZIP: 39817
FORMER COMPANY:
FORMER CONFORMED NAME: Danimer Scientific, Inc
DATE OF NAME CHANGE: 20201229
FORMER COMPANY:
FORMER CONFORMED NAME: Live Oak Acquisition Corp
DATE OF NAME CHANGE: 20200106
FORMER COMPANY:
FORMER CONFORMED NAME: Foxhound Merger Partners, Inc.
DATE OF NAME CHANGE: 20190605
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-29
0
0001779020
Danimer Scientific, Inc.
DNMR
0001140350
CROSKREY STEPHEN
C/O DANIMER SCIENTIFIC, INC.
140 INDUSTRIAL BOULEVARD
BAINBRIDGE
GA
39817
1
1
0
0
CEO and Chairman
Class A Common Stock ("Common Stock")
2020-12-29
4
A
0
4432261
A
4432261
D
Common Stock
2020-12-29
4
J
0
944144
24.20
D
3488117
D
Stock Option
24.20
2020-12-29
4
A
0
2571737
A
2030-12-29
Common Stock
2571737
2571737
D
Stock Option
24.20
2020-12-29
4
A
0
1154616
A
2030-12-29
Common Stock
1154616
1154616
D
Received in exchange for shares of common stock of Meredian Holdings Group, Inc., a Georgia corporation ("MHG") pursuant to the Agreement and Plan of Merger, dated as of October 3, 2020, by and among Live Oak Acquisition Corp., a Delaware corporation ("Live Oak"), Green Merger Corp., a Georgia corporation and wholly owned subsidiary of Live Oak ("Merger Sub"), MHG, Live Oak Sponsor Partners, LLC, as representative for Live Oak, and John A. Dowdy, Jr., as representative of the shareholders of the Company, as amended by Amendment No. 1, dated as of October 8, 2020, and Amendment No. 2, dated as of December 11, 2020, by and among all the parties thereto (as amended, the "Merger Agreement"), pursuant to which MHG became a direct, wholly-owned subsidiary of Live Oak, which subsequently changed its name to Danimer Scientific, Inc. (the "Issuer").
These shares of Common Stock were surrendered by the Reporting Person to the Issuer in satisfaction of outstanding indebtedness.
Options to purchase 857,245 shares of Common Stock will vest and become exercisable on or after December 29, 2021 if the closing price of a share of Common Stock equals or exceeds $14.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021, options to purchase 857,246 shares of Common Stock will vest and become exercisable on or after December 29, 2022 if the closing price of a share of Common Stock equals or exceeds $17.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021 and options to purchase 857,246 shares of Common Stock will vest and become exercisable on or after December 29, 2023 if the closing price of a share of Common Stock equals or exceeds $20.00 for any twenty (20) trading dates within a thirty (30)-day trading period beginning on December 29, 2021.
Granted pursuant to the terms of the Merger Agreement and issued under the Plan.
The option will not be exercisable until the later to occur of February 1, 2024 or the approval by the shareholders of the Issuer of an amendment to the Plan to increase the number of shares available under the Plan in an amount sufficient to permit the exercise of the option.
Granted in connection with the business combination contemplated by the Merger Agreement and issued under the Plan.
/s/ Stephen E. Croskrey
2020-12-31